6th Abu Dhabi Brain Conference
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th Abu Dhabi Brain Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
6th Abu Dhabi Brain Conference
Date: March 15–17, 2026
Venue: Abu Dhabi National Exhibition Centre (ADNEC), Abu Dhabi, UAE
Overview
The 6th Abu Dhabi Brain Conference returns as a premier global platform for neurologists, neuroscientists, clinicians, researchers, and healthcare professionals to explore cutting-edge advancements in brain health, neurological disorders, and innovative therapies. Held in the heart of Abu Dhabi, this conference bridges the gap between scientific discovery and clinical practice, fostering collaboration across borders and disciplines.
Who Attends
- Neurologists and neurosurgeons
- Neuroscientists and biomedical researchers
- Clinical psychologists and psychiatrists
- Academic institutions and university representatives
- Healthcare policymakers and administrators
- Medical device and pharmaceutical industry professionals
- Postgraduate students and early-career researchers
Conference Highlights
- Keynote addresses by leading global experts in neurodegenerative diseases, brain-computer interfaces, and mental health
- Interactive workshops on advanced diagnostic techniques and therapeutic interventions
- Exhibition of cutting-edge medical technologies and innovations in neurocare
- Oral and poster presentations showcasing groundbreaking research from around the world
- Networking opportunities with stakeholders from academia, industry, and government
- Special sessions on AI in neurology and ethical considerations in brain research
Keynote Speakers
- Dr. Maria Lopez, Director, Global Brain Health Institute, USA
- Prof. Ahmed Al-Maktoum, Neurosurgery Department, Sheikh Khalifa Medical City, UAE
- Dr. Sophia Jensen, Artificial Intelligence in Healthcare, Germany
- Dr. Rajiv Mehta, Cognitive Neuroscience Researcher, India
Registration Information
Early bird registration is open until January 15, 2026. Discounts are available for group bookings, students, and healthcare professionals from low- and middle-income countries. Visit www.abudhabibrainconference.com to register or contact info@abudhabibrainconference.com for further details.
Join us in Abu Dhabi to shape the future of brain health and neuroscience!
Data sheet
6th Abu Dhabi Brain Conference – Event Attendee & Buyer Profile Analysis
Event date: 18–20 September 2026
Location: InterContinental Hotel Abu Dhabi, Abu Dhabi, United Arab Emirates
Event status: Upcoming
Research date: 30 June 2026
Event Overview
| Event Name | 6th Abu Dhabi Brain Conference |
| Event Date | 18–20 September 2026 |
| Event Status | Upcoming |
| Venue | InterContinental Hotel Abu Dhabi |
| City | Abu Dhabi |
| State / Region | Abu Dhabi Emirate |
| Country | United Arab Emirates |
| Organizer | Organizer not publicly confirmed in the materials provided. |
| Official Event Website | Official event website not supplied in the request. |
| Event Type | Medical conference with scientific, clinical, research, networking, and solution-provider participation. |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Regional to international specialist medical audience, based on the event theme and supplied description. |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for numerical attendance; attendee profile is likely based on supplied event description and typical neurology conference structure. |
| Main Purpose of Event | To convene neurologists, neuroscientists, clinicians, researchers, healthcare leaders, and industry participants focused on brain health, neurological disorders, diagnostics, treatment innovation, and research collaboration. |
About the Event
The 6th Abu Dhabi Brain Conference is positioned as a specialist medical and scientific meeting focused on neurology, neuroscience, brain health, and related clinical and research advancements. Based on the supplied event description, the conference is designed to bring together neurologists, neurosurgeons, neuroscientists, psychiatrists, psychologists, biomedical researchers, healthcare administrators, academic institutions, and medical industry stakeholders.
From a commercial and lead-generation perspective, the event is most relevant for organizations serving hospitals, specialty clinics, academic medicine, neuroscience research programs, medical devices, pharmaceuticals, diagnostics, digital health, continuing medical education, and healthcare partnerships. It is less of a mass-trade expo and more of a high-value specialist conference where buyer influence tends to sit with clinical decision-makers, research leaders, department heads, hospital administrators, and industry partnership teams.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Neurologists and neurosurgeons | Hospitals, neurology centers, neuroscience institutes | Clinical evaluators, treatment influencers, departmental decision-makers | High relevance for devices, diagnostics, therapeutics, imaging, and education solutions |
| Neuroscientists and biomedical researchers | Universities, research institutes, translational medicine centers | Research tool selection, collaboration influence, grant-aligned procurement input | Relevant for lab technologies, research platforms, data tools, and scientific partnerships |
| Psychiatrists, psychologists, and mental health clinicians | Hospitals, behavioral health programs, mental health clinics | Care pathway influence and clinical adoption input | Relevant for neuropsychiatry solutions, diagnostics, digital therapeutics, and CME programs |
| Hospital administrators and healthcare executives | Public and private hospitals, specialty care groups | Budget holders, procurement approvers, strategic partnership decision-makers | High relevance for enterprise healthcare solutions, equipment, service contracts, and capability expansion |
| Academic institutions and university representatives | Medical schools, neuroscience faculties, teaching hospitals | Influence over research collaborations, training programs, and scientific procurement | Relevant for research partnerships, sponsorships, education technology, and training content |
| Healthcare policymakers and administrators | Health authorities, public healthcare systems, medical councils | Program influence, standards development, public health initiative input | Relevant for public-sector health innovation, care pathway design, and policy-aligned solution adoption |
| Medical device and diagnostics industry professionals | Device makers, neurotech firms, imaging and monitoring companies | Partnership, channel, and product evaluation roles | Useful for alliance building, distribution, co-development, and buyer education |
| Pharmaceutical and biotech professionals | Neuro-focused pharma, specialty therapeutics, biotech companies | Clinical collaboration, therapeutic education, investigator engagement | Relevant for partnerships, KOL engagement, trial awareness, and therapeutic launch support |
| Postgraduate students and early-career researchers | Universities, residency programs, fellowships | Low direct buying authority, high future influence | Relevant for awareness building, education products, and long-term relationship development |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Abu Dhabi | Local clinicians, hospital leaders, medical faculty, health-system stakeholders | High | Host-city attendance should be strongest among hospitals, specialty centers, and medical institutions. |
| Abu Dhabi Emirate | Regional healthcare providers, policymakers, and specialist physicians | High | Likely draw from public and private healthcare networks across the emirate. |
| Dubai and Northern Emirates | Specialist clinicians, academic participants, private healthcare executives | Medium to High | Likely feeder market due to UAE healthcare concentration and ease of travel. |
| GCC region | Neurology specialists, hospital groups, medical academics, health authorities | Medium | Strong relevance for Saudi Arabia, Qatar, Kuwait, Bahrain, and Oman if the conference maintains regional positioning. |
| Wider MENA | Specialist clinicians, researchers, and industry delegates | Medium | Likely where the event markets itself as a regional hub for brain health and neuroscience exchange. |
| International | Selected researchers, keynote speakers, industry partners, and international faculty | Medium | International reach is likely but not numerically confirmed in the supplied materials. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Primary Classification | Regional | The event appears best classified as a regional specialist medical conference with international participation potential, centered on the UAE and wider GCC/MENA brain health ecosystem. |
| Secondary Reach Description | International specialist appeal | The supplied description references global experts and cross-border collaboration, but current-year attendee distribution is not publicly confirmed. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Current-year buyer, sponsor, exhibitor, speaker-organization, or attendee-company lists were not provided in the request, and no official participation directory was supplied for validation. To avoid unsupported claims, named buyer organizations are not asserted as confirmed participants for the 2026 edition. This event is suitable for B2B attendee list building only after validating the official agenda, speaker roster, sponsor list, exhibitor manual, or registration partner directory. | |||||
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Head of Neurology | Clinical | Director / Department Head | Strong influence on specialty technology, treatment protocols, and departmental purchasing priorities. |
| 2 | Neurologist / Consultant Neurologist | Clinical | Manager / Senior Individual Contributor | Direct end-user and evaluator of diagnostics, neuro devices, therapies, and patient pathways. |
| 3 | Neurosurgery Department Chair | Clinical / Surgical Services | Director / Executive | Relevant for advanced procedures, operating technologies, and tertiary care capabilities. |
| 4 | Medical Director | Clinical Administration | Director | Approves clinical programs, partnerships, and service-line expansion decisions. |
| 5 | Hospital CEO / COO | Executive Management | C-Level | Important for strategic partnerships, capital investment, and enterprise agreements. |
| 6 | Director of Research / Principal Investigator | Research | Director / Senior Research Lead | Key for scientific platforms, trial support, data systems, and grant-backed procurement. |
| 7 | Procurement Manager | Procurement / Supply Chain | Manager | Controls sourcing, vendor qualification, contracting, and implementation timelines. |
| 8 | Clinical Affairs Director | Clinical Affairs | Director | Relevant for therapeutic partnerships, training, and evidence-based adoption. |
| 9 | Dean / Faculty Chair, Medical School | Academic Leadership | Executive / Director | Valuable for research collaborations, education partnerships, and institutional programs. |
| 10 | Partnerships Director / Business Development Director | Business Development | Director | Relevant for sponsorship, commercialization, distribution, and strategic collaboration. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core buyer base for clinical neurology and brain-health solutions | Hospital departments, specialist clinics, care networks |
| 2 | Medical Devices | Relevant for neurotechnology, monitoring, diagnostics, and treatment equipment | Device partnerships, distributor relationships, KOL outreach |
| 3 | Pharmaceuticals | Neurology and CNS therapeutic players are natural stakeholders | Therapy education, investigator engagement, disease-area partnerships |
| 4 | Biotechnology | Relevant for neurological research and translational medicine innovation | Research collaborations, biomarker and therapy development |
| 5 | Research | Academic and clinical research institutions are likely participants | Scientific tools, collaboration software, trial support services |
| 6 | Higher Education | Medical schools and universities are likely represented | Education partnerships, fellowships, lab and research procurement |
| 7 | Education Management | Relevant for clinical training and medical education partners | CME, skills training, digital education programs |
| 8 | Information Technology & Services | Relevant for health data, telemedicine, imaging workflows, and AI support | Clinical systems, analytics, patient management, interoperability |
| 9 | Computer Software | Applicable for digital therapeutics, imaging software, research data platforms | Clinical decision support, trial data, analytics tools |
| 10 | Government Administration | Health authorities and public health administrators may participate | Public-sector health initiatives, policy dialogue, system-wide programs |
| 11 | Health, Wellness & Fitness | Relevant for preventive brain health and rehabilitation support offerings | Rehab, patient engagement, wellness-aligned programs |
| 12 | Events Services | Useful for identifying organizing and conference-support stakeholders | Sponsorship and event-partner outreach |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No official attendance figure supplied | No supported numerical estimate included to avoid speculation. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No official exhibitor directory supplied | Event may include an exhibition component, but scale is not verified. |
| Buyer count | Not publicly confirmed | Unconfirmed | No buyer program or hosted-buyer data supplied | This is primarily a conference-driven medical audience rather than a formal hosted-buyer event. |
| Speaker count | Not publicly confirmed | Unconfirmed | No official agenda or faculty list supplied | Supplied description mentions leading global experts, but not a validated count. |
| Sponsor count | Not publicly confirmed | Unconfirmed | No sponsor list supplied | Sponsor analysis requires official prospectus or website validation. |
| Historical attendance | Historical attendance not provided | Historical / prior-year evidence unavailable in supplied data | No prior-year official metrics supplied | Prior-year participation evidence. Not a confirmed attendee list for the current edition. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Neurology care improvement | Better diagnostics, treatment pathways, and specialist outcomes | Clinical discussions with department heads and specialist physicians | Diagnostics, treatment support, care workflow solutions |
| Brain health research | Access to data, collaborations, tools, and translational support | Academic and investigator partnerships | Research platforms, software, lab systems, funded collaborations |
| Neurodiagnostics | Faster, more accurate assessment and monitoring | Demonstrations and clinician-led technical discussions | Imaging support, monitoring systems, decision support tools |
| Innovative therapies | Awareness of emerging treatment options and evidence | Medical affairs engagement, KOL sessions, therapy education | Pharma, biotech, and therapeutic partner offerings |
| Mental health integration | Cross-disciplinary coordination between neurology and psychiatry | Interdisciplinary care and referral pathway discussions | Assessment tools, digital health, therapy support services |
| Medical education | Continuous learning, specialist updates, peer exchange | Faculty engagement, accredited content, training partnerships | CME programs, training technologies, simulation, content licensing |
| Healthcare digital transformation | Workflow efficiency, patient data management, clinical analytics | Hospital IT and clinical leadership conversations | Healthcare software, analytics, interoperability, telehealth support |
| Partnerships and regional collaboration | Cross-border scientific and care-network collaboration | Institution-to-institution alliances and channel introductions | Distribution, co-development, education partnerships, joint programs |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The event is highly relevant for specialist healthcare, neurology, medical devices, pharma, and research-oriented solutions. |
| Decision-maker availability | Medium to High | Clinical heads, researchers, and hospital leaders are likely present, although formal procurement roles may be fewer than at dedicated sourcing events. |
| Data collection potential | Medium | Useful if official speaker, faculty, sponsor, and registration-partner data becomes available. Current supplied data is limited. |
| Apollo targeting potential | High | Apollo filters can effectively target hospitals, medical schools, medical-device firms, pharma, biotech, and research institutions across GCC and MENA. |
| Geographic targeting potential | High | The event naturally supports UAE, GCC, and broader MENA targeting for brain-health and neurology stakeholders. |
| Best outreach approach | High-value account-based outreach | Best results should come from focused outreach to department heads, medical directors, researchers, and hospital leadership rather than broad-volume campaigns. |
| Overall lead quality | High | High-value specialist audience, especially for clinical, research, device, pharma, and healthcare innovation offerings. |
| Best use case | Account-based lead generation and strategic partnership targeting | Most suitable for targeted prospecting, speaker/faculty mapping, sponsor engagement, and healthcare KOL outreach. |
| Limitations / risks | Medium | Current-year official participant data was not supplied, and there is a discrepancy between the known event details and the reference description. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Education Management; Information Technology & Services; Computer Software; Government Administration; Health, Wellness & Fitness | Build the core event-relevant healthcare and neuroscience audience universe. |
| Departments | Medical / Clinical; Research; Operations; Procurement; Information Technology; Business Development; Education | Capture both clinical buyers and institutional decision-influencers. |
| Seniority | C-Level; VP; Director; Head; Manager; Partner; Owner for specialist private clinics | Prioritize authority-bearing roles with budget, adoption, or partnership influence. |
| Job titles | Head of Neurology; Neurologist; Consultant Neurologist; Neurosurgeon; Medical Director; Hospital Director; Chief Medical Officer; Director of Research; Principal Investigator; Procurement Manager; Clinical Affairs Director; Dean; Faculty Chair; Partnerships Director; Business Development Director | Target high-fit specialist and institutional roles aligned to conference participation. |
| Geography | United Arab Emirates first; expand to Saudi Arabia, Qatar, Kuwait, Bahrain, Oman, Egypt, Jordan, and wider MENA as needed | Mirror the likely event catchment region. |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Best for hospitals, universities, healthcare groups, and established medical suppliers. |
| Keywords | neurology, neuroscience, brain health, neurocare, stroke, epilepsy, neurodiagnostics, neurorehabilitation, psychiatry, neuroscience research, medical education, CNS, cognitive health | Improve relevance for event-specific prospecting. |
| Technologies, if relevant | Clinical information systems, imaging systems, telehealth, EHR-related environments, healthcare analytics platforms | Useful for health-tech, software, and interoperability-driven outreach. |
| Revenue range, if relevant | Mid-market to enterprise healthcare institutions and established medical manufacturers | Focus on buyers with funding capacity and formal procurement structures. |
| Company type | Hospitals; academic medical centers; universities; research institutes; medical device manufacturers; pharmaceutical companies; biotech firms; health authorities | Align search strategy to the conference’s specialist medical ecosystem. |
Suggested Apollo Search Logic: Use a healthcare-specialist account list with combinations such as: ("neurology" OR "neuroscience" OR "brain health" OR "stroke" OR "epilepsy" OR "neurodiagnostics" OR "neurorehabilitation") AND industry filters for Hospital & Health Care, Medical Devices, Pharmaceuticals, Biotechnology, Research, and Higher Education. Layer title filters for Head of Neurology, Medical Director, Chief Medical Officer, Director of Research, Principal Investigator, and Procurement Manager in UAE and GCC geographies first.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-supplied known event details | Provided event data | Event name, city, country, venue, and dates used in this report: 18–20 September 2026 at InterContinental Hotel Abu Dhabi | Medium |
| User-supplied reference description | Reference text | Likely audience composition, event themes, and conference positioning | Medium |
| Internal verification note | Consistency review | A discrepancy exists between the supplied known details and the reference description. The reference text cites 15–17 March 2026 at ADNEC, while the known details cite 18–20 September 2026 at InterContinental Hotel Abu Dhabi. This report prioritizes the known details supplied in the request. | High |
| Official event website | Primary source needed | Would be required to confirm organizer, registration, sponsor list, faculty, exhibitors, and attendance numbers | Not reviewed in supplied materials |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th Abu Dhabi Brain Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds